ȸ¿ø±¤Àå °øÁö»çÇ×

°øÁö»çÇ×

[º¸µµÀÚ·á] [12.06.07]ÀÀ±ÞÇÇÀÓ¾àÀÇ ÀϹÝÀǾàÇ° ÀüȯÀ» ¹Ý´ëÇÑ´Ù(°øµ¿ ¼º¸í¼­)
µî·ÏÀÏ : 2012.06.07 Á¶È¸¼ö : 2930 ÀÛ¼ºÀÚ : »êÀÇȸ
 

´ëÇÑ»êºÎÀΰúÇÐȸ, ´ëÇÑ»êºÎÀΰúÀÇ»çȸ

°øµ¿ ¼º¸í¼­

ÀÀ±ÞÇÇÀÓ¾àÀÇ ÀϹÝÀǾàÇ° ÀüȯÀ» ¹Ý´ëÇÑ´Ù

- ÀÀ±ÞÇÇÀÓ¾àÀÇ Á¢±Ù¼º Çâ»óº¸´Ù ¿Ã¹Ù¸¥ ¼ºÀǽİú È¿°úÀûÀÎ ÇÇÀÓ±³À°ÀÌ ¼±ÇàµÇ¾î¾ß ¿øÄ¡ ¾Ê´Â ÀӽŰú ³«Å¸¦ ÁÙÀÏ ¼ö ÀÖ´Ù.-

ÀÌ ¶¥ÀÇ »êºÎÀΰú ÀÇ»çµéÀº ¿À´Ã ½ÄÇ°ÀǾàÇ°¾ÈÀüûÀÌ Àü¹®ÀǾàÇ°ÀÎ ÀÀ±ÞÇÇÀÓ¾àÀ» ÀϹÝÀǾàÇ°À¸·Î ÀüȯÇÑ´Ù´Â ¹ßÇ¥¸¦ Á¢ÇÏ°í ½É°¢ÇÑ ¿ì·Á¸¦ ±ÝÄ¡ ¸øÇϸç ÀÀ±ÞÇÇÀÓ¾àÀÇ ÀϹݾà ÀüȯÀÌ ºÒ·¯¿Ã °á°ú¿¡ ´ëÇØ ´ÙÀ½°ú °°ÀÌ °æ°íÇÏ´Â ¹ÙÀÌ´Ù.


1. ÀÀ±ÞÇÇÀÓ¾àÀÇ ¿À³²¿ëÀº ¿©¼ºµéÀÇ ¿øÄ¡ ¾Ê´Â ÀÓ½ÅÀ» ÁÙÀÌÁö ¸øÇÑ´Ù

: ÀÀ±ÞÇÇÀÓ¾àÀ» ÀϹݾàÀ¸·Î ÀüȯÇÑ ¹Ì±¹, ¿µ±¹, ³ë¸£¿þÀÌ, ½º¿þµ§, Áß±¹ µî¿¡¼­ ³«ÅÂÀ²ÀÌ ÁÙ¾îµé°ÍÀ̶ó´Â ´çÃÊ ±â´ë¿Í ´Þ¸® »çÀü ÇÇÀÓÀ» ¼ÒȦÈ÷ ÇÏ°Ô µÊÀ¸·Î½á ¿øÄ¡ ¾ÊÀº ÀӽŰú ³«Å´ °¨¼ÒÇÏÁö ¾Ê¾ÒÀ¸¸ç ƯÈ÷ û¼Ò³âÀÇ ÀӽŰú ¼ºº´ À¯º´À²ÀÌ ³ô¾ÆÁ³´Ù´Â ÇØ¿ÜÀÇ ¿¬±¸ °á°ú¿¡ ¿ì¸®´Â ÁÖ¸ñÇØ¾ß ÇÑ´Ù.<÷ºÎÀÚ·á 1>

Á¤»óÀûÀÎ ÇÇÀÓÀ²ÀÌ ¸Å¿ì ³·¾Æ »çȸ¹®Á¦°¡ µÇ°í ÀÖ´Â ¿ì¸®³ª¶ó°¡ ÀÀ±ÞÇÇÀÓ¾à ¸¶Àú ÀϹÝÀǾàÇ°À¸·Î ÀüȯµÈ´Ù¸é Á¤»óÀûÀÎ ÇÇÀÓÀ²ÀÇ Çâ»óÀº ´õ¿í ¾î·Á¿öÁö°í ³«Å ¿¹¹æ Á¤Ã¥ÀÇ ½ÇÆи¦ ÃÊ·¡ÇÏ°Ô µÉ °ÍÀÌ´Ù. Á¤ºÎ´Â ÇØ¿ÜÀÇ º¸°í¸¦ ¸íÈ®È÷ ÀνÄÇÏ°í, À̸¦ Ÿ»êÁö¼®À¸·Î »ï¾Æ¾ß ÇÒ °ÍÀ̸ç, ¿ì¸® »çȸÀÇ ¸¸¿¬ÇÑ ³«Å¸¦ ÁÙÀ̱â À§Çؼ­ °ú¿¬ ÀÀ±ÞÇÇÀÓ¾àÀÇ º¸±Þ È®´ë°¡ ¿ì¼± °í·ÁµÇ¾î¾ß ÇÒ Á¤Ã¥ »çÇ×ÀÎÁö ½É°¢ÇÏ°Ô Àç°íÇØ¾ß ÇÒ °ÍÀÌ´Ù. ¿ì¸® ¿©¼ºµéÀ» Á¤»óÀûÀÎ ÇÇÀÓÀ¸·Î º¸È£ÇÏÁö ¸øÇÏ°í ÀÀ±ÞÇÇÀÓ¾àÀ» ³²¿ë½ÃÄÑ ³«ÅÂ¿Í ¼ºº´ÀÇ À§Ç輺¿¡ ´õ ³ëÃâ½ÃÄÑ¾ß Çϰڴ°¡?

2. ÀÀ±ÞÇÇÀÓ¾àÀÇ ¿À³²¿ëÀº ¿©¼ºµéÀÇ »ý½Ä °Ç°­À» ½É°¢ÇÏ°Ô À§ÇùÇÑ´Ù.

: ÀÀ±ÞÇÇÀÓ¾àÀ̶õ °èȹÀÓ½ÅÀ» À§ÇÑ Á¤»óÀûÀÎ ÇÇÀÓ¹æ¹ýÀ» »ç¿ëÇÏ´ø Áß ºÒ°¡ÇÇÇÏ°Ô ½ÇÆÐÇÑ °æ¿ì³ª °­°£ µîÀÇ ÇÇÄ¡ ¸øÇÒ °æ¿ì ÀÀ±ÞÀ¸·Î »ç¿ëÇÏ´Â °í¿ë·®ÀÇ È£¸£¸ó(ÀϹÝÇÇÀÓ¾àÀÇ 10~15¹è)À¸·Î ¸¸µé¾îÁø ÀÀ±Þ¾àÀÌ´Ù. Á¤»óÀûÀÎ ÇÇÀÓ¾øÀÌ À̸¦ ÇÊ¿ä½Ã¸¶´Ù ¿À¿ëÇÏ¸é ±×È¿°ú°¡ ÁÙ¾îµé»Ó¸¸ ¾Æ´Ï¶ó ±× ³²¿ëÀ¸·Î ¿¹±âÄ¡ ¾ÊÀº ºÎÀÛ¿ë ¹× ÇÕº´ÁõÀ» ¾ß±âÇÏ°Ô µÈ´Ù. ÇÑ ¿ù°æÁֱ⿡ ¹Ýº¹Çؼ­ »ç¿ëÇÒ °æ¿ì ±× ºÎÀÛ¿ëÀÌ ½É°¢Çϸç Á¤»ó ¿ë·® ¹üÀ§ ¾È¿¡¼­ »ç¿ëÇÏ´õ¶óµµ ÃâÇ÷(31%), ¿À½É, º¹Åë µîÀÇ ºÎÀÛ¿ë ¹ßÇöÀÇ ºóµµ°¡ ³ô°í, ¹«¾ùº¸´Ù ÀÓ½ÅÀ̶ó´Â ½É°¢ÇÑ ºÎÀÛ¿ëÀÇ ¹ßÇöºóµµ°¡ ³ôÀº (ÇÇÀÓ½ÇÆÐÀ² 15~40%) ÀǾàÇ°ÀÌ´Ù.<Âü°íÀÚ·á 2>

¶ÇÇÑ ¾àÀÇ ºÎÀÛ¿ëÀ¸·Î ¹ß»ýÇÏ´Â ºÎÁ¤ÃâÇ÷À» ¿ù°æÀ¸·Î ¿ÀÇØÇÏ¿© ÀӽŠÁø´ÜÀÌ ´Ê¾îÁú ¼ö ÀÖ°í, ÀڱÿÜÀÓ½ÅÀ» ´Ê°Ô ¹ß°ßÇÏ¸é ³­°üÆÄ¿­ µîÀ¸·Î º¹°­³» ÃâÇ÷À» ÃÊ·¡ÇÏ°Ô µÇ¾î º¹¿ë ÈÄ ¼¼½ÉÇÑ °ü¸®°¡ ¾ø´Ù¸é ´ÙÀ½ Àӽſ¡ ½É°¢ÇÑ ¾Ç¿µÇâÀ» ¹ÌÄ¡°Ô µÈ´Ù.

ÀÌ·± À§Ç輺À» °®°í ÀÖ´Â ÀÀ±ÞÇÇÀÓ¾àÀ» ÀϹÝÀǾàÇ°À¸·Î ÀüȯÇÒ ¶§ ¹ß»ýÇÏ´Â ±¹¹Î°Ç°­ÀÇ ÇÇÇØ´Â Àý´ë ÆíÀǼºº¸´Ù ¿ì¼± µÉ¼ö ¾øÀ¸¸ç, ±× ÇÇÇØÀÇ Ã¥ÀÓÀº ÀüÀûÀ¸·Î Á¤ºÎ¿¡ ÀÖÀ½À» °æ°íÇÏ´Â ¹ÙÀÌ´Ù.


3. ÀÀ±ÞÇÇÀÓ¾àÀÇ Æí¸®ÇÑ »ç¿ë Áõ°¡°¡ ºÒ·¯¿À´Â °ÍÀº »çÀüÇÇÀÓ ¼ÒȦ·Î ÀÎÇÑ ¹«Ã¥ÀÓÇÑ ¼º¹®È­ È®»êÀÌ´Ù.

: ÇÇÀÓÈ¿°ú°¡ È®½ÇÇÑ Á¤»óÀûÀÎ ÇÇÀÓ¾à º¹¿ë·üÀÌ À¯·´°ú ¹Ì±¹¿¡¼­´Â 15~40%¿¡ À̸£´Â ¹Ý¸é, ¿ì¸®³ª¶ó´Â ¾à 2.5%¿¡ ºÒ°úÇϸç ÀÀ±ÞÇÇÀÓ¾àÀÇ º¹¿ë·üÀÌ ¿ÀÈ÷·Á ±× µÎ ¹è³ª µÇ´Â 5.6%¿¡ À̸£°í ÀÖ´Ù. <Âü°íÀÚ·á 3>

ÀÀ±ÞÇÇÀÓ¾àÀÇ ÀϹÝÀǾàÇ° ÀüȯÀº ÃÖ¼ÒÇÑ Á¤»óÀûÀÎ ÇÇÀÓ¾àÀÇ º¹¿ë·üÀÌ À¯·´À̳ª ¹Ì±¹ ¼öÁØÀÌ µÈ ÀÌÈÄ ³íÀÇ°¡ ½ÃÀ۵Ǿî¾ß ÇÒ °ÍÀ¸·Î, ¿ì¸® ³ª¶óÀÇ Çö½Ç¿¡´Â ½Ã±â»óÁ¶ÀÓÀÌ ¸í¹éÇÏ´Ù. ƯÈ÷ û¼Ò³âµéÀÇ ¹«ºÐº°ÇÑ ¼º ³ëÃâÀÌ Áõ°¡µÇ°í ÀÖ´Â ¿ì¸®³ª¶óÀÇ »óȲ¿¡¼­ ÀÀ±ÞÇÇÀÓ¾àÀÌ ÀϹÝÀǾàÇ°À¸·Î ÀüȯµÉ °æ¿ì ¿Ã¹Ù¸¥ ¼ºÀǽİú Á¤»óÀûÀÎ ÇÇÀÓ ¹®È­¸¦ Á¤Âø½ÃÄÑ ºÒ¹ý³«Å¸¦ ±ÙÀýÇÏ·Á´Â ³ë·Â¿¡ ¿ªÇàÇÏ´Â °á°ú¸¦ °¡Á®¿Ã ¼ö ¹Û¿¡ ¾ø´Ù.

ÀÀ±ÞÇÇÀÓ¾àÀÇ ÀϹÝÀǾàÇ° ÀüȯÀº ¿©¼ºÀÇ °Ç°­°ú ³«Å ¹®Á¦¿¡ Á÷°áµÇ´Â Áß´ëÇÑ »ç¾ÈÀÌ´Ù. ¿ì¸®³ª¶ó°¡ ¿øÄ¡ ¾Ê´Â ÀÓ½ÅÀ» ÁÙÀÌ°í ³«Å °øÈ­±¹ÀÇ ¿À¸í¿¡¼­ ¹þ¾î³ª´Â ±æÀº ÀÀ±ÞÇÇÀÓ¾à »ç¿ëÀ» ´Ã¸®´Â °ÍÀÌ ¾Æ´Ï¶ó Á¤»óÀûÀÎ ÇÇÀÓÀ²À» ³ôÀÌ°í Ã¥ÀÓ ÀÖ´Â ¼º¹®È­¸¦ Á¤ÂøÇÏ´Â °ÍÀÌ´Ù. ÀÀ±ÞÇÇÀÓ¾àÀ» ÀϹÝÀǾàÇ°À¸·Î ÀüȯÇÏ·Á´Â °èȹÀº Á¤»óÀûÀÎ ÇÇÀÓ¾à º¹¿ëÀÇ ºÒ¸ðÁöÀÎ ¿ì¸®³ª¶óÀÇ »óȲ¿¡ ½Ã±â»óÁ¶À̸ç, ÀÌ´Â ÇÇÀÓ¾àÀÇ º¹¿ë·üÀÌ ¼±Áø±¹ ¼öÁØÀ¸·Î ³ô¾ÆÁö°í ÇÇÀÓ ¹× ¼º¿¡ ´ëÇÑ ±¹¹ÎÀνÄÀÌ Á¤ÂøµÈ ÀÌÈÄ ´Ù½Ã ³íÀǵǾî¾ß ÇÒ »ç¾ÈÀÌ´Ù.

Á¤ºÎ´Â ±¹¹Îµé¿¡°Ô ÀÀ±ÞÇÇÀÓ¾àÀÇ È¿°ú¸¦ °ú½ÅÇÏÁö ¸»°í °èȹ ÀÓ½ÅÀ» À§ÇÑ Á¤»ó ÇÇÀÓÀ» È¿°úÀûÀ¸·Î Çϵµ·Ï ±³À°ÇÒ Àǹ«°¡ ÀÖÀ¸¸ç, ´õ ÀÌ»ó ÀÀ±Þ¾àÀÎ ÀÀ±ÞÇÇÀÓ¾àÀ» »ó¿ë¾àÀ¸·ÎÀνĽÃÅ°°í ±¹¹Î °Ç°­À» À§ÇùÇÏ´Â Á¤Ã¥À» ´çÀå ¸ØÃß¾î¾ß ÇÒ °ÍÀÌ´Ù.

ÀÌ¿¡ ¿©¼º°Ç°­À» ÃÖÀü¼±¿¡¼­ Ã¥ÀÓÁö°í ÀÖ´Â ´ëÇÑ»êºÎÀΰúÇÐȸ¿Í ´ëÇÑ»êºÎÀΰúÀÇ»çȸ´Â ȸ¿øµé°ú ÇÔ²² ±¹¹ÎµéÀÇ ÇÇÀÓ ±³À° ¹× »ó´ã¿¡ ÃÖ¼±ÀÇ ³ë·ÂÀ» ´ÙÇÒ °ÍÀ̸ç Á¤ºÎ°¡ À̸¦ Àû±ØÀûÀ¸·Î Áö¿øÇÏ´Â ¿Ã¹Ù¸¥ ÇÇÀÓ Á¤Ã¥À» ÆîÃÄÁֱ⸦ °­·ÂÇÏ°Ô ¿ä±¸ÇÏ´Â ¹ÙÀÌ´Ù.

2012. 6. 7.

´ëÇÑ»êºÎÀΰúÇÐȸ

´ëÇÑ»êºÎÀΰúÀÇ»çȸ


<Âü°íÀÚ·á1> ÀÀ±ÞÇÇÀÓ¾à Á¢±Ù¼ºÀ» ³ôÀÎ ³ª¶óµé¿¡¼­ ³«ÅÂÀ²°úÀÇ »ó°ü °ü°è º¸°í

1. 2011³â °¡Àå ÃÖ±Ù ¹®Çå

Increased access to ECP(Emergency contraceptive Pill) had a greater impact on repeat use among women who were at lower baseline risk of pregnancy. This may explain in part why increased access to ECP has had no measurable benefit in clinical trials. Regardless, even if ECP availability does adversely affect regular contraceptive use, women are entitled to know about all contraceptive options.

On the other hand, no published study has yet demonstrated that increasing access to ECPs can reduce pregnancy or abortion rates in a population.

À̶ó°í µÇ¾îÀÖÀ¸¸ç, °á·Ð¿¡¼­µµ

But it is unlikely that expanding access will have a major impact on reducing the rate of unintended pregnancy, primarily because the incidence of unprotected intercourse is so high, ECPs are only moderately effective, and ECPs are not used often enough. (ÀÀ±ÞÇÇÀÓ¾àÀÇ Á¢±Ù¼ºÀ» È®´ëÇÏ´Â °ÍÀÌ ºñ°èȹ ÀÓ½ÅÀÇ À²À» °¨¼Ò½ÃÅ°´Âµ¥ È¿°úÀûÀÌÁö ¸øÇÏ´Ù. ±× ÀÌÀ¯´Â ¹«¹æºñ ¼º±³ÀÇ ºóµµ°¡ Áõ°¡Çϸç, È¿°ú°¡ ³ôÁö ¾Ê°í, ½ÇÁ¦ ¾ÆÁÖ ¸¹ÀÌ »ç¿ëÇÏÁöµµ ¾Ê±â ¶§¹®ÀÌ´Ù.)

¶ó°í µÇ¾î ÀÖ½À´Ï´Ù.( Emergency contraception. J Trussell, E Raymond, 2011)

2.³ë¸£¿þÀÌ: 1995³â ÀÀ±ÞÇÇÀÓ¾àÀÌ Àü¹®ÀǾàÇ°À¸·Î Çã°¡, 2000³â ÀϹÝÀǾàÇ°À¸·Î ÀüȯµÊ. ÀϹÝÀǾàÇ° Àüȯ ÀÌÈÄ ÀÀ±ÞÇÇÀÓ¾à ÆǸŷ®Àº 30¹è ÀÌ»ó Áõ°¡ÇßÀ¸³ª ³«ÅÂÀ² °¨¼Ò È¿°ú´Â ¾ø¾úÀ½*

3. ¿µ±¹: ¿¬±¸ °á°ú¿¡ µû¸£¸é ÀÀ±ÞÇÇÀÓ¾àÀÇ ÀϹÝÀǾàÇ° Àüȯ ÀÌÈÄ, ÀÀ±ÞÇÇÀÓ¾à »ç¿ëÀº È®¿¬È÷ Áõ°¡ÇßÀ¸³ª ³«ÅÂÀ²Àº ÁÙ¾îµéÁö ¾Ê´Â °ÍÀ¸·Î º¸°íµÊ. ¶ÇÇÑ ÀÀ±ÞÇÇÀÓ¾àÀ» ¹Ì¸® Áغñ½ÃÄѵµ ³«ÅÂÀ²¿¡´Â ¿µÇâÀÌ ¾ø¾ú´Ù. µû¶ó¼­ º¸°Ç¼­ºñ½º¸¦ ÅëÇؼ­ ±¤¹üÀ§ÇÏ°Ô ÀÀ±ÞÇÇÀÓ¾àÀ» »çÀü º¸±ÞÇÏ´Â °ÍÀº ¿µ¿¬¹æ±¹°¡¿¡¼­ ÁغñµÇÁö ¾ÊÀº ÀÓ½ÅÀ²À» ³·Ãß´Â µ¥ È¿°úÀûÀÎ ¹æ¹ýÀÌ µÉ ¼ö ¾ø´Ù´Â °á·Ð.** 

4. ½º¿þµ§: Á¤ºÎ Åë°è ÀÚ·á¿¡ ÀÇÇϸé 2000³âºÎÅÍ 2007³â±îÁö ÀÀ±ÞÇÇÀÓ¾àÀÇ ¸ÅÃâ¾×Àº 3¹è °¡±îÀÌ ¼ºÀåÇÑ ¹Ý¸é °°Àº ±â°£ µ¿¾È ³«ÅÂÀ²Àº 17% Áõ°¡ (2001³âºÎÅÍ ÀÀ±ÞÇÇÀÓ¾àÀÇ OTC ÆǸŠÇã¿ë)***  

5.¹Ì±¹(1): ÀÀ±ÞÇÇÀÓ¾àÀÇ Á¢±Ù¼ºÀ» ³ô¿©µµ ÁغñµÇÁö ¾ÊÀº ÀÓ½ÅÀ̳ª ³«ÅÂÀÇ ºñÀ²À» Å©°Ô °¨¼Ò½ÃÅ°´Â Åë°èÀûÀÎ °á°ú¸¦ ¾òÁö ¸øÇÑ´Ù´Â °á·Ð#1

6. ¹Ì±¹(2):ÀÀ±ÞÇÇÀÓ¾àÀ» »çÀü Áö±ÞÇϰųª ¾à±¹¿¡¼­ ¹«»ó Áö±ÞÇÏ¿©µµ ÀÀ±ÞÇÇÀÓ¾à »ç¿ëÀ²¸¸ Áõ°¡ÇÏ°í ó¹æÇÒ¶§º¸´ÙÀÓ½ÅÀ²Àºº¯È­¾ø°í ¼ºº´Àº Áõ°¡ÇßÀ½#2

7.Áß±¹: ÀÀ±ÞÇÇÀÓ¾àÀ» ÀÚÀ¯·ÎÀÌ ±¸ÀÔÇÑ °æ¿ì ó¹æÇÑ °æ¿ìº¸´Ù ÀÀ±ÞÇÇÀÓ¾àÀ» 2¹è ´õ »ç¿ëÇßÀ¸¸ç, ÀÓ½ÅÀ²À̳ª³«ÅÂÀ²¿¡´Â Â÷ÀÌ°¡ ¾ø¾úÀ½##.

Âü°í¹®Çå

Polis CB, et al. Advance provision of emergency contraception for pregnancy prevention.Cochrane Database Syst Rev. 2007.

* Pedersen W. Emergency contraception: why the absent effect on abortion rates? ActaObstetricaetGynecologica. 2008

** Emergency contraception, British Medical Journal, 2006.

Glasier A. Advanced provision of emergency contraception does not reduce abortion rates. Contraception. 2004.

*** Abortion increase blamed on declining use of pill, The Local, 2008

#1 Raymond E. Effect of an emergency contraceptive pill intervention on pregnancy risk behavior.Contraception. 2008

#2 Raine T. Direct Access to Emergency Contraception Through Pharmacies and Effect on Unintended Pregnancy and STIs. JAMA. 2005;

## Hu X. Advanced provision of emergency contraception to postnatal women in China makes no difference in abortion rates. Contraception. 2005


<Âü°íÀÚ·á 2 >ÀÀ±ÞÇÇÀÓ¾àÀÇ ºÎÀÛ¿ë°ü·Ã ±Ù°ÅÀÚ·á

ÀÀ±ÞÇÇÀÓ¾à ³ë·¹º¸(·¹º¸³î°Ô½ºÆ®·¼ ´ÜÀÏ ÀÀ±ÞÇÇÀÓ¾à)ÀÇ ºÎÀÛ¿ëÀ¸·Î´Â ÃâÇ÷ÀÌ °¡Àå ¸¹¾Æ ¾à 1/3 (31%) ȯÀÚ°¡ ÃâÇ÷À» È£¼ÒÇÑ´Ù (Ç¥1. Helena von Hertzen, LANCET, WHO 2002). ÃâÇ÷ÀÇ ¾çÀÌ ¸¹Àº °æ¿ì¿¡´Â ¾îÁö·¯¿ò°ú ºóÇ÷À» ÀÏÀ¸Å°¸ç ±ÞÈ÷ ÀÀ±Þ½Ç·Î ¿À´Â ȯÀڵ鵵 ÀÖ´Ù. ¸¹Àº ¿©¼ºÀÌ À̸¦ ¡®»ý¸®¡¯·Î ¿ÀÀÎÇÏ°í ¡®ÀÓ½ÅÀÌ µÇÁö ¾Ê¾Ò´Ù¡¯°í ¾È½ÉÇÏ´Ù°¡ µÚ´Ê°Ô ÀÓ½ÅÀ» ¹ß°ßÇÑ´Ù´Â ¹®Á¦Á¡ÀÌ ÀÖ´Ù.

ÀÀ±ÞÇÇÀÓ¾àÀº Á¤»ó ¿ë·® ¹üÀ§ ¾È¿¡¼­ »ç¿ëÇÏ´õ¶óµµ ÃâÇ÷(31%), ¿À½É(14~23.1%), º¹Åë(14~17.6%), ¹«±â·Â(14~16.9%), µÎÅë(10~16.8%), ¾îÁö·³Áõ(10~11.2%) µîÀÇ ºÎÀÛ¿ë ¹ßÇöÀÇ ºóµµ°¡ ³ôÀº ÀǾàÇ°À̸ç, ÀÓ½ÅÀ̶ó´Â ½É°¢ÇÑ ºÎÀÛ¿ëÀÇ ¹ßÇöºóµµ°¡ ³ôÀº (ÇÇÀÓ½ÇÆÐÀ² Æò±Õ 15%) ÀǾàÇ°À̹ǷΠÀü¹®ÀǾàÇ°À̾î¾ß ÇÑ´Ù.

[ÀÀ±ÞÇÇÀӾ࿡ ´ëÇÑ WHOÀÇ 1998³â ¹× 2002³â ´ë´ÜÀ§ Á¶»ç¿¡ ´ëÇÑ ³í¹®¿¡¼­´Â ÇϱâÀÇ Ç¥¿Í °°Àº ºÎÀÛ¿ëÀ» ¼³¸íÇÏ°í ÀÖ´Ù.]

1) von Hertzen H, Piaggio G, Ding J, Chen J, Song S, Bartgai G, et al. WHO Research Group on Post-Ovulatory Methods of Fertility Regulation. Low dose mifepristone and two regimens of levonorgestrel for emergency contraception: a WHO multicentrerandomised trial, Lancet 360:1803-10, 2002.

2) World Health Organization Task Force on Postovulatory Methods of Fertility Regulation. Randomized controlled trial of levonorgestrel versus the Yuzpe regimen of combined oral contraceptives for emergency contraception. Lancet 1998;352:428.


[Ç¥. ÀÀ±Þ ÇÇÀÓ¾à °¢°¢ÀÇ ºÎÀÛ¿ë ºóµµ]

 

 

Yuzpe method

(WHO, 1998)

 

Levonorgestrel

0.75mg X 2

(WHO, 1998)

Levonorgestrel

0.75mg X 2

(WHO, 2002)

Levonorgestrel

1.5mg

(WHO, 2002)

¿À½É

50.5

23.1

15

14

±¸Åä

18.8

5.6

1

1

¾îÁö·³Áõ

16.7

11.2

9

10

¹«±â·Â

28.5

16.9

13

14

µÎÅë

20.2

16.8

10

10

À¯¹æÅë

12.1

10.8

8

8

º¹Åë

20.9

17.6

15

14

ÃâÇ÷

 

 

31

31

7ÀÏÀÌ»óÀÇ»ý¸®Áö¿¬

 

 

5

5

¹øÈ£Á¦¸ñÀÛ¼ºÀÚµî·ÏÀÏÁ¶È¸
18344 [°í½Ã°ø°í]

[¾È³»]2023³â °áÇÙ°ü¸®º¸¼ö±³À°(¿Â¶óÀÎ) ¼¼ºÎÀÏÁ¤ ¹× ¼ö°­ ¾È³»(Áúº´°ü¸®Ã»...

»êÀÇȸ 23.08.25 33
18343 [°í½Ã°ø°í]

[°í½Ã]¡¸¿ä¾ç±Þ¿©ÀÇ Àû¿ë±âÁØ ¹× ¹æ¹ý¿¡ °üÇÑ ¼¼ºÎ»çÇס¹°í½Ã ÁúÀÇÀÀ´ä Ãß°¡...

»êÀÇȸ 23.08.18 61
18342 [°í½Ã°ø°í]

[¾È³»]Äڷγª19 ¿¹¹æÁ¢Á¾ ¹é½Å º¸°ü °ü¸® öÀú ¾È³»

»êÀÇȸ 23.08.14 46
18341 [°í½Ã°ø°í]

[¾È³»]Áúº´°ü¸®Ã» Àẹ°áÇÙ°¨¿°°ËÁø ½Ç½Ã Ư·Ê °èµµ±â°£ ¿î¿µ¿¡ µû¸¥ Àç¾È³»...

»êÀÇȸ 23.08.11 45
18340 [°í½Ã°ø°í]

[¾È³»]¼ö¼ú½Ç CCTV ¼³Ä¡ °ü·Ã ½ÃÇà Àû¿ë ¹üÀ§ ¾È³»

»êÀÇȸ 23.08.09 67
18339 [°í½Ã°ø°í]

[¾È³»]ºñ´ë¸éÁø·á ½Ã¹ü»ç¾÷ ÃÊÁø ´ë»óÀÚ ¡¸¼öÁøÀÚ ÀÚ°ÝÁ¶È¸¡¹ Á¦°ø °ü·Ã ¾È...

»êÀÇȸ 23.08.09 43
18338 [°í½Ã°ø°í]

[¾È³»]2021³â(11Â÷) ´ç´¢º´ ÀûÁ¤¼º Æò°¡°á°ú ¾È³»

»êÀÇȸ 23.08.07 44
18337 [°í½Ã°ø°í]

[¾È³»]2023³â ºñ±Þ¿© Áø·áºñ¿ë °ø°³ °ü·Ã ÀÚ·áÁ¦Ãâ 2Â÷ ¾È³»

»êÀÇȸ 23.08.04 46
18336 [°í½Ã°ø°í]

[¾È³»]ÀÇ·á¿ë ¸¶¾à·ù "ÃÖ¸éÁøÁ¤Á¦" ¹× "¸¶ÃëÁ¦" ¾ÈÀü»ç...

»êÀÇȸ 23.08.02 50
18335 [°í½Ã°ø°í]

[¾È³»]Áø·á½É»çÆò°¡À§¿øȸ ½ÉÀÇ»ç·Ê ¾È³»(2023³â 7¿ù)

»êÀÇȸ 23.08.01 45
18334 [°øÁö»çÇ×]

[¾È³»] 2023³â ¿¹¹æÁ¢Á¾¾÷¹« À§Å¹ÀÇ·á±â°ü ¿¹¹æÁ¢Á¾ºñ¿ë °ø°í ¾È³»(6Â÷)

»êÀÇȸ 23.07.31 39
18333 [°í½Ã°ø°í]

[¾È³»] 2023-2024Àý±â ÀÎÇ÷翣ÀÚ ¹é½Å °ø±Þ°ü·Ã ÇùÁ¶¿äû

»êÀÇȸ 23.07.31 51
18332 [º¸µµÀÚ·á]

[230728]½Å»ý¾Æ ³ú¼º¸¶ºñ 12¾ï ÆÇ°á °ü·Ã ´ëÇÑ»êºÎÀΰúÀÇ»çȸ ¼º¸í¼­

»êÀÇȸ 23.07.28 157
18331 [°øÁö»çÇ×]

[¾È³»]ÇÑÀÇ»ç ÃÊÀ½Æıâ±â »ç¿ë °ü·Ã ÆÇ°á¿¡ ´ëÇÑ Åº¿ø¼­ Á¦Ãâ ¿äû

»êÀÇȸ 23.07.27 36
18330 [°í½Ã°ø°í]

[¾È³»]2023³â 2Â÷ ÀÌÇпä¹ý ÇàÀ§ °ü·Ã Àåºñ Á¤ºñ ¾È³»

»êÀÇȸ 23.07.25 46
18329 [°í½Ã°ø°í]

[¾È³»]°Ëü°Ë»ç À§Å¹¿¡ °üÇÑ ±âÁØ °ü·Ã ¾È³»¹®

»êÀÇȸ 23.07.24 58
18328 [°í½Ã°ø°í]

[¾È³»]2023³â ÇϹݱâ Èñ¼Ò ±ä±ÞµµÀÔ ÇÊ¿ä ÀÇ·á±â±â ÁöÁ¤ ¼ö¿äÁ¶»ç ½Ç½Ã ¾È³»...

»êÀÇȸ 23.07.19 45
18327 [°í½Ã°ø°í]

[¾È³»] ÀÇ·á±â±â ȸ¼ö Á¾·á º¸°í(¾Ë¸²)[¼ÒÇÁÆ®¿£¹ÙÀÌ¿À(ÁÖ)]

»êÀÇȸ 23.07.19 40
18326 [°í½Ã°ø°í]

[¾È³»]2023-2024Àý±â ÀÎÇ÷翣ÀÚ ¹é½Å ¿¹»ó¼ö¿ä·® µî·Ï ¾È³»

»êÀÇȸ 23.07.14 44
18325 [°í½Ã°ø°í]

[¾È³»]DUR-ITS Á¤º¸ Á¦°ø ±¹°¡ º¯°æ ¾È³»

»êÀÇȸ 23.07.14 47